[Federal Register Volume 67, Number 5 (Tuesday, January 8, 2002)]
[Notices]
[Pages 922-923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-419]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importation of Controlled Substances; Notice of Application

    Pursuant to section 1008 of the Controlled Substances Import and 
Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in Schedule I or II and prior to issuing a 
regulation under Section 1002(a) authorizing the importation of such a 
substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with Sec. 1301.34 of Title 21, Code of 
Federal Regulations (CFR), notice is hereby given that on August 17, 
2001, Cerilliant Corporation, 14050 Summit Drive, Suite 121, PO Box 
80189, Austin, Texas 78708-0189, made application by renewal to the 
Drug Enforcement Administration to be registered as an importer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
Gamma hydroxybutyric acid (2010)...........  I
Ibogaine (7260)............................  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
4-Bromo-2, 5-dimetnoxyamphetamine (7391)...  I
4-Bromo-2, 5-dimethoxyphenethylamine (7392)  I
4-Methyl-2, 5-dimethoxyamphetamine (7395)..  I
2, 5-Dimethoxyamphetamine (7396)...........  I
3, 4-Methylenedioxyamphetamine (7400)......  I
3, 4-Methylenedioxy-N-ethylamphetamine       I
 (7404).
3, 4-Methylenedioxymethamphetamine (7405)..  I
4-Methoxyamphetamine (7411)................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
Heroin (9200)..............................  I
Pholcodine (9314)..........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Etorphine (9056)...........................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Benzoylecgonine (9180).....................  II
Ethylmorphine (9190).......................  II
Meperidine (9230)..........................  II
Methadone (9250)...........................  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Morphine (9300)............................  II
Thebaine (9333)............................  II
Levo-alphacetylmethadol (9648).............  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------

    The firm plans to import small quantities of the listed controlled 
substances for the manufacturer of analytical reference standards.
    Any manufacturer holding, or applying for, registration as a bulk 
manufacturer of these basic classes of controlled substances may file 
written comments on or objections to the application described above 
and may, at the same time, file a written request for a hearing on such 
application in accordance with 21 CFR 1301.43 in such form as 
prescribed by 21 CFR 1316.47.
    Any such comments, objections or requests for a hearing may be 
addressed, in quintuplicate, to the Deputy Assistant Administrator, 
Office of Diversion Control, Drug Enforcement Administration, United 
States Department of Justice, Washington, DC. 20537, Attention: DEA 
Federal Register Representative (CCR), and must be filed no later than 
February 7, 2002.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e), and (f). As noted

[[Page 923]]

in a previous notice at 40 FR 43745-46 (September 23, 1975), all 
applicants for registration to import the basic classes of any 
controlled substances in Schedule I or II are and will continue to be 
required to demonstrate to the Deputy Assistant Administrator, Office 
of Diversion Control, Drug Enforcement Administration that the 
requirements for such registration pursuant to 21 U.S.C. 958(a), 21 
U.S.C. 823(a), and 21 CFR 1301.34(a), (b), (c), (d), (e), and (f) are 
satisfied.

    Dated: December 21, 2001.
Laura M. Nagel,
Deputy Assistant Adminstrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-419 Filed 1-7-02; 8:45 am]
BILLING CODE 4410-09-M